Ribosomal protein L5 pseudogene 27 (RPL5P27)

RPL5P27 (Ribosomal protein L5 pseudogene 27) is a processed pseudogene annotated in the human genome and does not encode a functional protein[3]. It is one of several pseudogene copies of the ribosomal protein L5 gene (RPL5), which is a true protein-coding gene and a component of the ribosomal 60S subunit involved in ribosome biogenesis and cellular protein synthesis[4][5]. Unlike the parent gene, RPL5P27 is generally not transcribed into a functional protein and is not known to participate directly in biological pathways or disease phenotypes[3].\nPseudogenes such as RPL5P27 are commonly present in the genome due to duplication or retrotransposition events and are not considered therapeutic targets—they do not function as enzymes, receptors, transporters, or fulfill other roles typical for drug targets[3][4][5].\nThere is no evidence supporting a role for RPL5P27 as a biomarker, in disease, or as a molecular target for drugs. If you are seeking ribosomal protein L5 as a potential drug target or disease marker, refer instead to the RPL5 gene/protein, not the pseudogene[4][5].\nTherefore, RPL5P27 is *not* a therapeutic target, and its entry as a target is technically incorrect.

Other names

RPL5P27Ribosomal protein L5 pseudogene 27